FARALLON CAPITAL MANAGEMENT LLC Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$18.0B
Holdings
228
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (228 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SPYSPDR S&P 500 ETF TR | 2,235,000 | $885.8B | 4914.42% | Put |
| 2 | GOOGALPHABET INC | 404,351 | $836.5B | 4640.65% | |
| 3 | IQVIQVIA HLDGS INC | 4,069,181 | $785.9B | 4360.31% | |
| 4 | WTWWILLIS TOWERS WATSON PLC LTD | 3,124,200 | $715.1B | 3967.20% | |
| 5 | AONAON PLC | 2,454,194 | $564.7B | 3133.16% | |
| 6 | TMOTHERMO FISHER SCIENTIFIC INC | 1,155,078 | $527.2B | 2924.66% | |
| 7 | TMUST-MOBILE US INC | 4,108,826 | $514.8B | 2856.09% | |
| 8 | BSXBOSTON SCIENTIFIC CORP | 12,822,869 | $495.6B | 2749.62% | |
| 9 | MSFTMICROSOFT CORP | 1,916,248 | $451.8B | 2506.56% | |
| 10 | FISFIDELITY NATL INFORMATION SV | 3,142,318 | $441.8B | 2451.34% | |
| 11 | METAFACEBOOK INC | 1,399,205 | $412.1B | 2286.38% | |
| 12 | ARMKARAMARK | 10,868,450 | $410.6B | 2278.07% | |
| 13 | WABWABTEC | 4,946,946 | $391.6B | 2172.60% | |
| 14 | RTXRAYTHEON TECHNOLOGIES CORP | 4,782,411 | $369.5B | 2050.20% | |
| 15 | CNCCENTENE CORP DEL | 5,625,000 | $359.5B | 1994.48% | |
| 16 | XLRNACCELERON PHARMA INC | 2,600,000 | $352.6B | 1956.15% | |
| 17 | MAMASTERCARD INCORPORATED | 985,920 | $351.0B | 1947.56% | |
| 18 | BXBLACKSTONE GROUP INC | 4,431,121 | $330.3B | 1832.24% | |
| 19 | AVGOBROADCOM INC | 682,247 | $316.3B | 1755.01% | |
| 20 | IPHIINPHI CORP | 1,744,800 | $311.3B | 1727.04% | |
| 21 | CRMSALESFORCE COM INC | 1,426,875 | $302.3B | 1677.23% | |
| 22 | ELVANTHEM INC | 825,000 | $296.1B | 1642.96% | |
| 23 | SHWSHERWIN WILLIAMS CO | 395,141 | $291.6B | 1617.90% | |
| 24 | TRUTRANSUNION | 3,160,077 | $284.4B | 1577.89% | |
| 25 | CHTRCHARTER COMMUNICATIONS INC N | 454,178 | $280.2B | 1554.76% | |
| 26 | —GW PHARMACEUTICALS PLC | 1,278,900 | $277.4B | 1538.98% | |
| 27 | VVISA INC | 1,308,829 | $277.1B | 1537.45% | |
| 28 | AMRSEURAMYRIS INC | 13,500,000 | $257.9B | 1430.56% | |
| 29 | EX9EXELIXIS INC | 10,750,000 | $242.8B | 1347.30% | |
| 30 | HLTHILTON WORLDWIDE HLDGS INC | 1,949,437 | $235.7B | 1307.81% | |
| 31 | —BHP GROUP PLC | 4,000,521 | $231.5B | 1284.20% | |
| 32 | EDUNEW ORIENTAL ED & TECHNOLOGY | 15,943,000 | $223.2B | 1238.33% | |
| 33 | FATEFATE THERAPEUTICS INC | 1,900,000 | $156.7B | 869.12% | |
| 34 | BABAALIBABA GROUP HLDG LTD | 676,400 | $153.4B | 850.84% | |
| 35 | IOVAIOVANCE BIOTRAPEUTICS INC | 4,750,000 | $150.4B | 834.34% | |
| 36 | MRTXEURMIRATI THERAPEUTICS INC | 850,000 | $145.6B | 807.82% | |
| 37 | LULUFAX HOLDING LTD | 9,833,399 | $142.8B | 792.15% | |
| 38 | ASNDASCENDIS PHARMA A/S | 1,000,000 | $128.9B | 715.03% | |
| 39 | —QIAGEN NV | 2,538,423 | $123.6B | 685.71% | |
| 40 | NYTNEW YORK TIMES CO | 2,379,622 | $120.5B | 668.29% | |
| 41 | EFXEQUIFAX INC | 606,629 | $109.9B | 609.61% | |
| 42 | PLYAPLAYA HOTELS & RESORTS NV | 14,994,867 | $109.5B | 607.30% | |
| 43 | ALNYALNYLAM PHARMACEUTICALS INC | 700,000 | $98.8B | 548.33% | |
| 44 | ENTAENANTA PHARMACEUTICALS INC | 1,995,000 | $98.4B | 545.89% | |
| 45 | MOMO 1.25 07/01/25MOMO INC | 110,077,000 | $96.8B | 537.21% | |
| 46 | HWMHOWMET AEROSPACE INC | 2,955,729 | $95.0B | 526.88% | |
| 47 | APLSAPELLIS PHARMACEUTICALS INC | 2,175,000 | $93.3B | 517.79% | |
| 48 | GBIOGBXGENERATION BIO CO | 3,270,500 | $93.1B | 516.40% | |
| 49 | PCGPG&E CORP | 7,292,042 | $85.4B | 473.74% | |
| 50 | KRTXKARUNA THERAPEUTICS INC | 675,000 | $81.2B | 450.25% | |
| 51 | CLGXCORELOGIC INC | 975,000 | $77.3B | 428.69% | |
| 52 | BCABBIOATLA INC | 1,492,060 | $75.9B | 420.85% | |
| 53 | IQ 2 04/01/25IQIYI INC | 81,762,000 | $75.7B | 420.07% | |
| 54 | —BROADMARK RLTY CAP INC | 7,170,213 | $75.0B | 416.10% | |
| 55 | RVMDREVOLUTION MEDICINES INC | 1,609,730 | $73.9B | 409.74% | |
| 56 | 2L9BLUEPRINT MEDICINES CORP | 694,791 | $67.6B | 374.80% | |
| 57 | AGIOAGIOS PHARMACEUTICALS INC | 1,250,000 | $64.5B | 358.12% | |
| 58 | PTGXPROTAGONIST THERAPEUTICS INC | 2,425,000 | $62.8B | 348.46% | |
| 59 | ARNAEURARENA PHARMACEUTICALS INC | 850,000 | $59.0B | 327.23% | |
| 60 | FGENEURFIBROGEN INC | 1,683,700 | $58.4B | 324.23% | |
| 61 | CYTKCYTOKINETICS INC | 2,500,000 | $58.1B | 322.62% | |
| 62 | —THERAVANCE BIOPHARMA INC | 56,695,000 | $57.9B | 321.41% | |
| 63 | INSM 1.75 01/15/25INSMED INC | 50,000,000 | $56.6B | 314.12% | |
| 64 | CARAEURCARA THERAPEUTICS INC | 2,465,000 | $53.5B | 296.90% | |
| 65 | APH1EURAPHRIA INC | 2,765,800 | $50.8B | 281.88% | |
| 66 | KRYSKRYSTAL BIOTECH INC | 625,000 | $48.1B | 267.14% | |
| 67 | LNTHLANTHEUS HLDGS INC | 2,250,000 | $48.1B | 266.77% | |
| 68 | BEAMBEAM THERAPEUTICS INC | 592,481 | $47.4B | 263.10% | |
| 69 | —TURNING POINT THERAPEUTICS I | 500,000 | $47.3B | 262.39% | |
| 70 | —ATENTO S A | 2,230,357 | $46.8B | 259.73% | |
| 71 | —RADIUS HEALTH INC | 2,107,400 | $44.0B | 243.89% | |
| 72 | —ZOGENIX INC | 2,250,000 | $43.9B | 243.67% | |
| 73 | ANNXANNEXON INC | 1,455,846 | $40.5B | 224.87% | |
| 74 | CLVS 1.25 05/01/25CLOVIS ONCOLOGY INC | 51,910,000 | $39.2B | 217.72% | |
| 75 | —IKENA ONCOLOGY INC | 1,349,513 | $38.1B | 211.51% | |
| 76 | RPREALPAGE INC | 415,000 | $36.2B | 200.77% | |
| 77 | QTRXQUANTERIX CORP | 600,000 | $35.1B | 194.64% | |
| 78 | NVV1NOVAVAX INC | 175,000 | $31.7B | 176.03% | |
| 79 | PLRXPLIANT THERAPEUTICS INC | 764,262 | $30.1B | 166.76% | |
| 80 | —IQIYI INC | 29,689,000 | $29.6B | 164.46% | |
| 81 | BIIBBIOGEN INC | 103,000 | $28.8B | 159.86% | |
| 82 | ISIIONIS PHARMACEUTICALS INC | 630,500 | $28.3B | 157.27% | |
| 83 | —KHOSLA VENTURES ACQUT CO III | 2,809,000 | $28.1B | 155.69% | |
| 84 | VAREURVARIAN MED SYS INC | 150,000 | $26.5B | 146.91% | |
| 85 | NUVBNUVATION BIO INC | 2,500,000 | $26.1B | 144.94% | |
| 86 | SG7SAGE THERAPEUTICS INC | 345,000 | $25.8B | 143.27% | |
| 87 | KPTI 3 10/15/25KARYOPHARM THERAPEUTICS INC | 25,000,000 | $25.5B | 141.69% | |
| 88 | —ISIS PHARMACEUTICALS INC DEL | 24,435,000 | $24.8B | 137.57% | |
| 89 | TGTXTG THERAPEUTICS INC | 500,000 | $24.1B | 133.71% | |
| 90 | —CLEVER LEAVES HOLDINGS INC | 2,278,079 | $23.4B | 130.05% | |
| 91 | —CONSTELLATION PHARMCETICLS I | 1,000,000 | $23.4B | 129.77% | |
| 92 | ORTXUSDORCHARD THERAPEUTICS PLC | 3,215,434 | $23.3B | 129.51% | |
| 93 | —KHOSLA VENTURES ACQUSTN CO I | 2,250,000 | $22.7B | 125.96% | |
| 94 | SRPTSAREPTA THERAPEUTICS INC | 300,000 | $22.4B | 124.05% | |
| 95 | IQ 4 12/15/26IQIYI INC | 20,000,000 | $20.7B | 114.76% | |
| 96 | —REVOLUTION HEALTHCAR AQ CORP | 2,000,000 | $20.1B | 111.52% | |
| 97 | —DECARBONIZATION PLUS ACQU II | 2,000,000 | $19.9B | 110.52% | |
| 98 | —ZYMEWORKS INC | 600,000 | $18.9B | 105.12% | |
| 99 | —FIVE PRIME THERAPEUTICS INC | 501,618 | $18.9B | 104.84% | |
| 100 | —FORTRESS VALUE ACQUISI CORP | 1,750,000 | $17.3B | 96.12% |
Page 1 of 3Next